Health economics perspective of fesoterodine, tolterodine...

Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain

Sicras-Mainar, Antoni, Rejas, Javier, Navarro-Artieda, Ruth, Aguado-Jodar, Alba, Ruiz-Torrejón, Amador, Ibáñez-Nolla, Jordi, Kvasz, Marion
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
BMC Urology
DOI:
10.1186/1471-2490-13-51
Date:
December, 2013
File:
PDF, 377 KB
english, 2013
Conversion to is in progress
Conversion to is failed